MET and neoplasm: The aberrant c-Met activity by mutation, amplification, or overexpression could promote tumor cell survival, growth, invasion, and metastasis through excessive stimulation of multiple downstream signaling pathways, including RAS/MAPK and PI3K/AKT pathways.